Health Catalyst Inc (HCAT)

$7.73

-0.06

(-0.77%)▲

Market is closed - opens 7 PM, 29 Jul 2024

Performance

  • $7.62
    $8.13
    $7.73
    downward going graph

    1.42%

    Downside

    Day's Volatility :6.27%

    Upside

    4.92%

    downward going graph
  • $5.45
    $14.37
    $7.73
    downward going graph

    29.5%

    Downside

    52 Weeks Volatility :62.07%

    Upside

    46.21%

    downward going graph

Returns

PeriodHealth Catalyst IncSector (Health Care)Index (Russel 2000)
3 Months
29.19%
6.5%
0.0%
6 Months
-24.37%
7.1%
0.0%
1 Year
-41.56%
9.8%
0.0%
3 Years
-86.08%
14.2%
-20.2%

Highlights

Market Capitalization
449.8M
Book Value
$6.06
Earnings Per Share (EPS)
-1.84
Wall Street Target Price
11.46
Profit Margin
-35.56%
Operating Margin TTM
-24.07%
Return On Assets TTM
-7.27%
Return On Equity TTM
-27.69%
Revenue TTM
296.8M
Revenue Per Share TTM
5.19
Quarterly Revenue Growth YOY
1.2%
Gross Profit TTM
135.6M
EBITDA
-51.2M
Diluted Eps TTM
-1.84
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.35
EPS Estimate Next Year
0.51
EPS Estimate Current Quarter
0.03
EPS Estimate Next Quarter
0.08

Analyst Recommendation

Buy
    73%Buy
    26%Hold
    0
    0%Sell
Based on 23 Wall street analysts offering stock ratings for Health Catalyst Inc(by analysts ranked 0 to 5 stars)
Based on 23 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
17
18
18
Hold
6
5
5
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 48.25%

Current $7.73
Target $11.46

Company Financials

FY18Y/Y Change
Revenue
112.6M
↑ 54.04%
Net Income
-62.0M
↑ 31.78%
Net Profit Margin
-55.06%
↑ 9.3%
FY19Y/Y Change
Revenue
154.9M
↑ 37.63%
Net Income
-60.1M
↓ 3.05%
Net Profit Margin
-38.79%
↑ 16.27%
FY20Y/Y Change
Revenue
188.8M
↑ 21.88%
Net Income
-115.0M
↑ 91.39%
Net Profit Margin
-60.91%
↓ 22.12%
FY21Y/Y Change
Revenue
241.9M
↑ 28.11%
Net Income
-153.2M
↑ 33.21%
Net Profit Margin
-63.33%
↓ 2.42%
FY22Y/Y Change
Revenue
276.2M
↑ 14.18%
Net Income
-137.4M
↓ 10.32%
Net Profit Margin
-49.74%
↑ 13.59%
FY23Y/Y Change
Revenue
295.9M
↑ 7.13%
Net Income
-118.1M
↓ 14.01%
Net Profit Margin
-39.92%
↑ 9.82%
Q4 FY22Q/Q Change
Revenue
69.2M
↑ 1.18%
Net Income
-35.8M
↓ 21.76%
Net Profit Margin
-51.74%
↑ 15.17%
Q1 FY23Q/Q Change
Revenue
73.9M
↑ 6.8%
Net Income
-33.2M
↓ 7.24%
Net Profit Margin
-44.93%
↑ 6.81%
Q2 FY23Q/Q Change
Revenue
73.2M
↓ 0.89%
Net Income
-32.6M
↓ 1.74%
Net Profit Margin
-44.55%
↑ 0.38%
Q3 FY23Q/Q Change
Revenue
73.8M
↑ 0.76%
Net Income
-22.0M
↓ 32.44%
Net Profit Margin
-29.86%
↑ 14.69%
Q4 FY23Q/Q Change
Revenue
75.1M
↑ 1.78%
Net Income
-30.3M
↑ 37.58%
Net Profit Margin
-40.37%
↓ 10.51%
Q1 FY24Q/Q Change
Revenue
74.7M
↓ 0.48%
Net Income
-20.6M
↓ 32.08%
Net Profit Margin
-27.55%
↑ 12.82%
FY18Y/Y Change
Total Assets
111.0M
↑ 0.64%
Total Liabilities
485.7M
↑ 31.37%
FY19Y/Y Change
Total Assets
302.4M
↑ 172.46%
Total Liabilities
101.7M
↓ 79.06%
FY20Y/Y Change
Total Assets
577.7M
↑ 91.08%
Total Liabilities
301.6M
↑ 196.55%
FY21Y/Y Change
Total Assets
832.1M
↑ 44.03%
Total Liabilities
310.0M
↑ 2.77%
FY22Y/Y Change
Total Assets
752.3M
↓ 9.59%
Total Liabilities
327.3M
↑ 5.57%
FY23Y/Y Change
Total Assets
701.8M
↓ 6.71%
Total Liabilities
334.9M
↑ 2.33%
Q4 FY22Q/Q Change
Total Assets
752.3M
↓ 3.08%
Total Liabilities
327.3M
↓ 2.66%
Q1 FY23Q/Q Change
Total Assets
752.3M
↑ 0.0%
Total Liabilities
347.2M
↑ 6.07%
Q2 FY23Q/Q Change
Total Assets
722.9M
↓ 3.91%
Total Liabilities
333.0M
↓ 4.07%
Q3 FY23Q/Q Change
Total Assets
712.9M
↓ 1.38%
Total Liabilities
330.5M
↓ 0.75%
Q4 FY23Q/Q Change
Total Assets
701.8M
↓ 1.56%
Total Liabilities
334.9M
↑ 1.32%
Q1 FY24Q/Q Change
Total Assets
695.1M
↓ 0.95%
Total Liabilities
337.9M
↑ 0.9%
FY18Y/Y Change
Operating Cash Flow
-40.3M
↑ 9.41%
Investing Cash Flow
21.4M
↓ 4.49%
Financing Cash Flow
24.3M
↓ 2.11%
FY19Y/Y Change
Operating Cash Flow
-32.2M
↓ 20.13%
Investing Cash Flow
-209.6M
↓ 1079.31%
Financing Cash Flow
231.4M
↑ 850.39%
FY20Y/Y Change
Operating Cash Flow
-26.1M
↓ 18.75%
Investing Cash Flow
-82.6M
↓ 60.61%
Financing Cash Flow
182.6M
↓ 21.08%
FY21Y/Y Change
Operating Cash Flow
-23.1M
↓ 11.57%
Investing Cash Flow
-139.7M
↑ 69.17%
Financing Cash Flow
264.1M
↑ 44.62%
FY22Y/Y Change
Operating Cash Flow
-35.3M
↑ 52.53%
Investing Cash Flow
-39.0M
↓ 72.06%
Financing Cash Flow
-2.6M
↓ 100.99%
Q4 FY22Q/Q Change
Operating Cash Flow
-14.8M
↑ 23.19%
Investing Cash Flow
6.3M
↓ 118.85%
Financing Cash Flow
637.0K
↓ 108.45%
Q1 FY23Q/Q Change
Operating Cash Flow
-5.6M
↓ 62.35%
Investing Cash Flow
22.6M
↑ 262.04%
Financing Cash Flow
93.0K
↓ 85.4%
Q2 FY23Q/Q Change
Operating Cash Flow
-11.6M
↑ 107.42%
Investing Cash Flow
-7.4M
↓ 132.74%
Financing Cash Flow
1.2M
↑ 1192.47%

Technicals Summary

Sell

Neutral

Buy

Health Catalyst Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Health Catalyst Inc
Health Catalyst Inc
27.7%
-24.37%
-41.56%
-86.08%
-79.66%
Solventum Corp
Solventum Corp
13.4%
-16.71%
-16.71%
-16.71%
-16.71%
Veeva Systems Inc.
Veeva Systems Inc.
1.24%
-10.63%
-7.18%
-43.19%
9.43%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
2.46%
9.25%
3.22%
32.12%
32.12%
Healthequity Inc
Healthequity Inc
-3.68%
3.76%
26.99%
6.89%
-2.18%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Health Catalyst Inc
Health Catalyst Inc
NA
NA
NA
0.35
-0.28
-0.07
NA
6.06
Solventum Corp
Solventum Corp
NA
NA
NA
6.26
0.17
0.08
NA
NA
Veeva Systems Inc.
Veeva Systems Inc.
54.35
54.35
1.35
4.76
0.13
0.06
NA
30.25
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
23.5
23.5
20.11
4.27
0.22
0.06
0.0
16.23
Healthequity Inc
Healthequity Inc
85.91
85.91
2.29
2.19
0.04
0.03
NA
24.11
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Health Catalyst Inc
Health Catalyst Inc
Buy
$449.8M
-79.66%
NA
-35.56%
Solventum Corp
Solventum Corp
Hold
$10.8B
-16.71%
NA
15.73%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$29.8B
9.43%
54.35
22.34%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$36.9B
32.12%
23.5
8.05%
Healthequity Inc
Healthequity Inc
Buy
$6.9B
-2.18%
85.91
7.71%

Insights on Health Catalyst Inc

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 75.08M → 74.72M (in $), with an average decrease of 0.5% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -30.31M → -20.58M (in $), with an average increase of 47.2% per quarter

  • Vs HQY

    In the last 1 year, Healthequity Inc has given 27.0% return, outperforming this stock by 68.6%

  • Vs HQY

    In the last 3 years, Healthequity Inc has given 6.9% return, outperforming this stock by 93.0%

Institutional Holdings

  • BlackRock Inc

    9.09%

  • Vanguard Group Inc

    7.58%

  • Wellington Management Company LLP

    4.45%

  • Bank of New York Mellon Corp

    4.22%

  • Daventry Group, LP

    3.66%

  • Impax Asset Management Group PLC

    3.65%

Company Information

health catalyst is dedicated to enabling health care organizations to fundamentally improve care by building the most comprehensive and fully integrated suite of healthcare data warehousing and process improvement solutions available. health catalyst was formed by a group of healthcare veterans with vast data warehousing and quality improvement experience. our founders and executives collaborated for nearly a decade to revolutionize clinical process models using analytics. during development, they faced numerous hurdles in the quest to develop a data warehouse that could handle the complexities unique to healthcare data. after determining that the predominant approaches to data modeling weren’t effective for healthcare data, they discovered the solution, which is now known as the adaptive data architecture. using a late-binding bus architecture, catalyst’s adaptive data model is agile, flexible, and can be implemented in a matter of weeks compared to the months or years traditional app

Organization
Health Catalyst Inc
Employees
1300
CEO
Mr. Daniel D. Burton
Industry
Technology Services

Discover More

FAQs